Stocksigma LogoStocksigma Logo

Ishita Drugs Reports Q2 Results And Progresses Facility Upgradation

Ishita Drugs and Industries reported revenue from operations of Rs. 303.31 lakh for the quarter ended 30th Sep'26, down from Rs. 314.53 lakh in Q1 and Rs

Ishita Drugs Reports Q2 Results And Progresses Facility Upgradation

Ishita Drugs & Industries Ltd 路 Financial Result 路 03 Nov 2026, 10:57 pm

Ishita Drugs Reports Q2 Results And Progresses Facility Upgradation Ishita Drugs and Industries reported revenue from operations of Rs. 303.31 lakh for the quarter ended 30th Sep'26, down from Rs. 314.53 lakh in Q1 and Rs. 306.81 lakh YoY. Net profit stood at Rs. 16.08 lakh versus Rs. 23.02 lakh QoQ and Rs. 14.33 lakh YoY. Basic EPS was Rs. 0.54. Separately, the board reviewed its Schedule M manufacturing facility upgrade; the company spent ~Rs. 488 lakh on civil work and paid Rs. 190 lakh in capex, partly funded via a Rs. 51.90 lakh HDFC Bank loan disbursement.

Original exchange filing (PDF)

More announcements from Ishita Drugs & Industries Ltd

All Ishita Drugs & Industries Ltd announcements